Literature DB >> 12375022

Effect of survivin on cell proliferation and apoptosis in gastric cancer.

Yoichi Wakana1, Kazuhiko Kasuya, Soh Katayanagi, Akihiko Tsuchida, Tatsuya Aoki, Yasuhisa Koyanagi, Hideaki Ishii, Yoshiro Ebihara.   

Abstract

We investigated the effect of expression of survivin, an apoptosis inhibiting protein, on cellular proliferation and apoptosis in gastric cancer and assessed its relation to the pathological characteristics of gastric cancer. Resected gastric cancer specimens from 42 patients (intestinal type; 21 cases and diffuse type; 21 cases) were evaluated. There were no significant differences in the clinicopathologic factors between the two groups. Survivin mRNA expression was measured using real-time reverse transcription-polymerase chain reaction, and survivin protein expression was evaluated by immunohistochemical staining. The Ki-67 index was adopted for cell proliferation scoring, and the ss-DNA positive rate as an apoptotic index. The survivin mRNA expression inversely correlated with the apoptotic index (p<0.05). Survivin mRNA expression (p<0.001) and survivin protein expression (p<0.001) were significantly higher in the diffuse type than the intestinal type. In conclusion, gastric cancer avoids cellular death by survivin expression and this tendency was more conspicuous in diffuse type gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375022

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721.

Authors:  Sheng-Quan Cheng; Wen-Liang Wang; Wei Yan; Qing-Long Li; Li Wang; Wen-Yong Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma.

Authors:  Chao-Ping Ye; Cheng-Zhi Qiu; Zhong-Xin Huang; Qi-Chen Su; Wei Zhuang; Rui-Lan Wu; Xin-Feng Li
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

3.  Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis.

Authors:  Andreas Krieg; Billur Baseras; Monika Tomczak; Pablo Emilio Verde; Nikolas Hendrik Stoecklein; Wolfram Trudo Knoefel
Journal:  Mol Biol Rep       Date:  2013-08-15       Impact factor: 2.316

4.  Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.

Authors:  Kyung Hee Lee; Eun Young Choi; Sung Ae Koh; Min Kyoung Kim; Kyeong Ok Kim; Si Hyung Lee; Byung Ik Jang; Se Won Kim; Sang Woon Kim; Sun Kyo Song; Joon Hyuk Choi; Jae-Ryong Kim
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

5.  Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer.

Authors:  Rui Li; Wei-Chang Chen; Xue-Qin Pang; Wen-Yan Tian; Wei-Peng Wang; Xue-Guang Zhang
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

6.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

7.  Expression level of wild-type survivin in gastric cancer is an independent predictor of survival.

Authors:  Hua Meng; Cai-De Lu; Yu-Lei Sun; De-Jian Dai; Sang-Wong Lee; Nobuhiko Tanigawa
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition.

Authors:  Satoshi Mamori; Tadashi Asakura; Kiyoshi Ohkawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

9.  Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.

Authors:  Michiko Shintani; Akiko Sangawa; Naoki Yamao; Shingo Kamoshida
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

10.  Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells.

Authors:  Guo-Ying Miao; Qi-Ming Lu; Xiu-Lan Zhang
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.